QUADROVAX

Description

QUADROVAX (Diphtheria, Tetanus, Pertussis (Whole Cell) and Haemophilus Type b Conjugate Vaccine) consists of Hib  vaccine (Haemophilus Type b Conjugate Vaccine) as a freeze dried powder and Triple Antigen liquid (DTP) as a diluent for reconstitution.

Triple Antigen contains diphtheria toxoid, tetanus toxoid and killed Bordetella pertussis bacilli. The Hib polysaccharide is prepared from capsular polysaccharide of H. influenzae type b strain and after activation, is coupled to Tetanus Toxoid.

QUADROVAX is indicated for the active immunization of infants, at or above the age of 6 weeks against Diphtheria, Tetanus , whooping cough and Haemophilus Influenzae type b infections.  QUADROVAX does not protect against disease due to other types of H.influenzae nor against meningitis caused by other organisms.

Immunization guideline:

For active immunization of infants and preschool children, it is recommended that three intramuscular injections of 0.5ml be administered with an interval of four weeks between doses starting at six weeks of age.

A booster dose of DTP and Hib can be given at the age of 15-18 months.

A reinforcing injection of DTP should be administered at 5 years of age (i.e. at the time of school entry).

For latest IAP updates see revised immunization schedule.

Additional information

manufacturer

Serum Institute of India Ltd.

country-of-manufacture

India

vaccine-type

Diphtheria-Tetanus-Pertussis (whole cell)-Haemophilus influenzae type b

pharmaceutical-form

Liquid, Lyophilized

package-size

1 Dose

route-of-administration

Intramuscular

Contraindications

Hypersensitivity to any component of the vaccine, presence of any evolving neurological condition and Encephalopathy after a previous dose. Immunization should be postponed during the cause of an acute illness and severe, febrile illness. Elective immunization procedures should be deferred during an outbreak of poliomyelitis.

preservative

Thiomersal